Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females

Anderson, E.L., Fraser, A., McNally, W., Sattar, N. , Lashen, H., Fleming, R., Nelson, S.M. and Lawlor, D.A. (2013) Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females. PLoS ONE, 8(5), e64510. (doi:10.1371/journal.pone.0064510) (PMID:23762215) (PMCID:PMC3675909)

[img]
Preview
Text
83238.pdf - Published Version
Available under License Creative Commons Attribution.

317kB

Abstract

Objectives: Epidemiological evidence for associations of Anti-Müllerian hormone (AMH) with cardiometabolic risk factors is lacking. Existing evidence comes from small studies in select adult populations, and findings are conflicting. We aimed to assess whether AMH is associated with cardiometabolic risk factors in a general population of adolescent females.

Methods: AMH, fasting insulin, glucose, HDLc, LDLc, triglycerides and C-reactive protein (CRP) were measured at a mean age 15.5 years in 1,308 female participants in the Avon Longitudinal Study of Parents and Children (ALSPAC). Multivariable linear regression was used to examine associations of AMH with these cardiometabolic outcomes.

Results: AMH values ranged from 0.16–35.84 ng/ml and median AMH was 3.57 ng/ml (IQR: 2.41, 5.49). For females classified as post-pubertal (n = 848) at the time of assessment median (IQR) AMH was 3.81 ng/ml (2.55, 5.82) compared with 3.25 ng/ml (2.23, 5.05) in those classed as early pubertal (n = 460, P≤0.001). After adjusting for birth weight, gestational age, pubertal stage, age, ethnicity, socioeconomic position, adiposity and use of hormonal contraceptives, there were no associations with any of the cardiometabolic outcomes. For example fasting insulin changed by 0% per doubling of AMH (95%CI: −3%,+2%) p = 0.70, with identical results if HOMA-IR was used. Results were similar after additional adjustment for smoking, physical activity and age at menarche, after exclusion of 3% of females with the highest AMH values, after excluding those that had not started menarche and after excluding those using hormonal contraceptives.

Conclusion: Our results suggest that in healthy adolescent females, AMH is not associated with cardiometabolic risk factors.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Nelson, Professor Scott and Fleming, Professor Richard and Sattar, Professor Naveed and McNally, Mr William
Authors: Anderson, E.L., Fraser, A., McNally, W., Sattar, N., Lashen, H., Fleming, R., Nelson, S.M., and Lawlor, D.A.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:PLoS ONE
Publisher:Public Library of Science
ISSN:1932-6203
Copyright Holders:Copyright © 2013 The Authors
First Published:First published in PLoS ONE 8(5):e64510
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
451351Maternal over nutrition and offspring fat mass, metabolic and vascular functionNaveed SattarNational Institute of Health (USA) (NIH(US))R01 DK077659-01RI CARDIOVASCULAR & MEDICAL SCIENCES